| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |